Multisystem Inflammatory Syndrome in Children with COVID-19: Clinical Profile and Comparison in Two Age Groups
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in multisystem inflammatory syndrome in children (MIS-C). It manifests later in the course of SARS-CoV-2 infection and presents with higher severity. Aim: To describe the clinical spectrum of illness and to...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jaypee Brothers Medical Publisher
2023-04-01
|
| Series: | Pediatric Infectious Disease |
| Subjects: | |
| Online Access: | https://www.pidjournal.com/doi/PID/pdf/10.5005/jp-journals-10081-1389 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in multisystem inflammatory syndrome in children (MIS-C). It manifests later in the course of SARS-CoV-2 infection and presents with higher severity.
Aim: To describe the clinical spectrum of illness and to compare the clinical profile, management and outcome in two age groups; upto 5 years and >5 years.
Materials and methods: Observational study. Children satisfying World Health Organization (WHO) MIS-C criteria admitted in the hospital during the study period were included in the study.
Results: A total of 44 children were included in the study. The median age was 6.5 years, interquartile range (IQR) was 3.92 to 10 years. Gastrointestinal symptoms were the commonest presentation, 70.45%. Gastrointestinal symptoms and shock were seen in children of >5 years and the difference was statistically significant. Hyperferritinemia and lymphopenia were statistically significant in the older age group. Intravenous immunoglobulin (IVIG) was used in 88.24% of children up to 5 years of age group. Around 55.56% of children of >5 years were managed with steroids alone.
Conclusion: The course and short-term outcome of MIS-C are generally favorable. |
|---|---|
| ISSN: | 2582-4988 |